| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/14/2011 | CN102276687A Method for separating golden vinegar polypeptide extracts from golden vinegar and product thereof |
| 12/14/2011 | CN102276662A 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用 Sialic acid (α- (2 → 6)) - D- pyranose derivatives and synthetic methods and applications |
| 12/14/2011 | CN102276495A 3-氨基-2-羟基苯丙酸类金属蛋白酶抑制剂及其制备方法和应用 3-amino-2-hydroxyphenyl propionic acid inhibitor of metalloproteinase and its preparation method and application |
| 12/14/2011 | CN102274522A 用于伤口愈合的体内基因转移 For wound healing in vivo gene transfer |
| 12/14/2011 | CN102274511A 一种用于治疗病毒性肝炎的药物组合物 A pharmaceutical composition for the treatment of viral hepatitis |
| 12/14/2011 | CN102274493A 一种可用于微创美容疗法的止血消炎镇痛复合功效纳米乳及其制备方法 An anti-inflammatory that can be used to stop bleeding minimally invasive cosmetic treatments analgesic efficacy composite nanoemulsion and its preparation method |
| 12/14/2011 | CN102274492A 骨合成代谢蛋白质的药物递送方法 Bone anabolic protein drug delivery methods |
| 12/14/2011 | CN102274491A 用于促进缺血组织血管生成的干细胞联合生长因子注射液及其制备方法和使用方法 Promote angiogenesis in ischemic tissue stem cells and growth factor injection and its preparation method and use for |
| 12/14/2011 | CN102274490A 一种用于治疗或预防癌症的药物 A drug for treating or preventing cancer |
| 12/14/2011 | CN102274489A 治疗或预防癌症的药物 Treating or preventing cancer drugs |
| 12/14/2011 | CN102274488A 一种治疗或预防癌症的药物 A medicament for the treatment or prevention of cancer |
| 12/14/2011 | CN102274487A 重组灵芝免疫调节蛋白在制备治疗化疗药所致白细胞减少症药物中的应用 Ganoderma immunomodulatory recombinant therapeutic proteins in the preparation of chemotherapy-induced leukopenia Drug Application |
| 12/14/2011 | CN102274486A 一种人体外用复方制剂及其用途 Type of human topical compound preparation and their use |
| 12/14/2011 | CN102274485A 一种抗菌肽缓释微球制剂及其制备方法 A slow-release microsphere formulation and preparation of antimicrobial peptides |
| 12/14/2011 | CN102274241A 提取羊胚胎提取物的方法及含有该提取物的药物组合物 The method of extracting sheep embryo extract and pharmaceutical compositions containing the extract |
| 12/14/2011 | CN102274186A 一种用于抗癌的镜像多肽脂质纳米制剂 Mirroring peptide lipid nano-formulations for cancer |
| 12/14/2011 | CN102274183A 一种多囊脂质体制备方法和应用 A multi-sac liposome preparation methods and applications |
| 12/14/2011 | CN102274182A 一种含有艾塞那肽的多囊脂质体及其制备方法和应用 Multivesicular liposomes and its preparation method and application containing exenatide |
| 12/14/2011 | CN101972229B 一种过氧化氢酶固体脂质纳米粒制剂的制备方法 A method for preparing catalase SLN formulations over |
| 12/14/2011 | CN101905017B Method for preparing chitosan nanoparticles |
| 12/14/2011 | CN101805408B 抗肿瘤溶栓双效嵌合蛋白及其制备方法和应用 Anti-tumor effect of thrombolytic double chimeric protein and its preparation method and application |
| 12/14/2011 | CN101716336B 一种益康胶囊及其生产制作工艺 One kind of production process and production Yikang Capsules |
| 12/14/2011 | CN101585868B 一种麒麟菜天然色素糖蛋白的提取方法及其应用 A method of extracting natural pigment Eucheuma glycoprotein and its application |
| 12/14/2011 | CN101514354B 一种海参多肽及其制备方法与应用 Sea cucumber peptide and its preparation method and application |
| 12/14/2011 | CN101434656B Opg-hsp70融合蛋白的制备方法及用途 Opg-hsp70 fusion protein preparation and use |
| 12/14/2011 | CN101402680B 鲨鱼肝再生因子、其制备方法及其医药用途 Shark liver regeneration factor, their preparation and their medicinal uses |
| 12/14/2011 | CN101396347B 一种重组人血管内皮抑制素缓释微球的制备方法 A recombinant human endostatin release microsphere preparation |
| 12/14/2011 | CN101273988B 氨基咪唑甲酰胺和5-氨基或取代的氨基1,2,3-三唑的盐在制备治疗和预防肿瘤药物中的用途 Aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazole salt thereof in the manufacture of a medicament for the treatment and prevention of cancer of use |
| 12/14/2011 | CN101245109B 一种聚乙二醇单修饰的重组人粒细胞集落刺激因子突变体及其制备方法 One polyethylene glycol mono-modified recombinant human granulocyte colony-stimulating factor mutant and its preparation method |
| 12/14/2011 | CN101210261B 星虫多肽的制备方法及其应用 Preparation and application esculenta polypeptide |
| 12/14/2011 | CN101189021B 用于控制、预防和治疗肥胖和进食障碍的组合物和方法 Compositions and methods for the control, prevention and treatment of obesity and eating disorders |
| 12/14/2011 | CN101115388B 细胞透化和稳定试剂及其使用方法 Cell permeability and stability of the reagents and methods of use |
| 12/13/2011 | US8078511 Method and system for foreign exchange price procurement and automated hedging |
| 12/13/2011 | US8077851 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls |
| 12/13/2011 | US8076472 RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA) |
| 12/13/2011 | US8076469 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection |
| 12/13/2011 | US8076463 Polymer-von Willebrand factor-conjugates |
| 12/13/2011 | US8076456 Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof |
| 12/13/2011 | US8076452 Streptavidin-binding peptide |
| 12/13/2011 | US8076450 Administering an acid sensing ion channel inhibitor; therapy or prevention of brain injuries |
| 12/13/2011 | US8076449 polypeptide containing an amino acid sequence represented by Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro; or having a deletion, substitution, insertion of above sequence or modified polypeptide; Alzheimer's disease, amyotrophic lateral sclerosis |
| 12/13/2011 | US8076412 Water-soluble polymer alkanals |
| 12/13/2011 | US8076300 FGF2-binding peptides and uses thereof |
| 12/13/2011 | US8076299 Method for producing peptide thioester |
| 12/13/2011 | US8076297 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 12/13/2011 | US8076296 Cosmetic compositions |
| 12/13/2011 | US8076295 Peptide amphiphiles having improved solubility and methods of using same |
| 12/13/2011 | US8076294 Collagen-related peptides and uses thereof |
| 12/13/2011 | US8076293 Use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption |
| 12/13/2011 | US8076292 Factor VIII: remodeling and glycoconjugation of factor VIII |
| 12/13/2011 | US8076291 Treatment for obesity |
| 12/13/2011 | US8076290 Stabilizing alkylglycoside compositions and methods thereof |
| 12/13/2011 | US8076289 Fibrosis inhibitor for implanted organ |
| 12/13/2011 | US8076288 Hybrid polypeptides having glucose lowering activity |
| 12/13/2011 | US8076287 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals |
| 12/13/2011 | US8076286 Antimicrobial peptides and use thereof |
| 12/13/2011 | US8076285 Lysobactin amides |
| 12/13/2011 | US8076284 Analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5 |
| 12/13/2011 | US8076283 Methods for treating congestive heart failure |
| 12/13/2011 | US8076282 Composition for improving membrane composition and functioning of cells |
| 12/13/2011 | US8076281 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment |
| 12/13/2011 | US8076132 Dendritic cell tumor injection (DCTI) therapy |
| 12/13/2011 | US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/13/2011 | US8076096 Alteration of cell membrane with FasL |
| 12/13/2011 | US8076091 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof |
| 12/13/2011 | US8076087 Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 12/13/2011 | US8076086 Methods of modulating the activity of TANGO332 |
| 12/13/2011 | US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 12/13/2011 | US8075922 Method of co-infusing a deoxygenated hemoglobin containing blood substitute and inorganic nitrite |
| 12/13/2011 | US8075919 Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation |
| 12/13/2011 | US8075916 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 12/13/2011 | US8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
| 12/13/2011 | US8075900 Melanoma associated peptide analogues and vaccines against melanoma |
| 12/13/2011 | US8075899 Peptides of the A-chain of proinsulin or insulin |
| 12/13/2011 | US8075897 Allergen peptide fragments and use thereof |
| 12/13/2011 | US8075894 Use of soluble CD164 in inflammatory and/or autoimmune disorders |
| 12/13/2011 | US8075892 Treatment with anti-ErbB2 antibodies |
| 12/13/2011 | US8075890 Method for making humanized antibodies |
| 12/13/2011 | US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides |
| 12/13/2011 | US8075878 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 12/13/2011 | US8075877 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 12/13/2011 | CA2576647C Vla-4 antagonists |
| 12/13/2011 | CA2476247C Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| 12/13/2011 | CA2475821C Group b streptococcus antigens |
| 12/13/2011 | CA2470743C Corticotropin releasing factor 2 receptor agonists |
| 12/13/2011 | CA2457215C Process for preparing glycopeptide derivatives |
| 12/13/2011 | CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 12/13/2011 | CA2402238C Polypeptides having neutrophil stimulating activity |
| 12/13/2011 | CA2386954C Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 12/13/2011 | CA2378373C Production of rhpbgd and new therapeutic methods for treating patients with acute intermittent porphyria (aip) and other porphyric diseases |
| 12/13/2011 | CA2358520C Soluble receptor br43x2 and methods of using |
| 12/08/2011 | WO2011153531A1 Method of treating skeletal dysplasias using vessel dilator |
| 12/08/2011 | WO2011153525A2 Methods for treatment of nephrotic syndrome and related conditions |
| 12/08/2011 | WO2011153512A2 Use of compounds with thrombopoietic activity to promote bone growth and healing |
| 12/08/2011 | WO2011153491A2 Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
| 12/08/2011 | WO2011153429A2 Methods of treatment |
| 12/08/2011 | WO2011153277A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 12/08/2011 | WO2011153235A2 Compositions featuring superoxide dismutase polypeptides having enhanced anti-oxidant activity |
| 12/08/2011 | WO2011153209A2 Cd36 inhibition to control obesity and insulin sensitivity |
| 12/08/2011 | WO2011152995A1 Synthetic proteins containing t cell epitopes for use as immunogenic compositions |